Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rynacrom 4% nasal spray
1202010P0BBAEAG
|
Rynacrom | Sodium cromoglicate | Ear, Nose and Oropharynx | No data available |
|
Rynacrom Allergy nasal spray
1202010P0BBAFAF
|
Rynacrom | Sodium cromoglicate | Ear, Nose and Oropharynx | No data available |
|
Rythmodan 100mg capsules (Imported Canada)
0203020F0BCACAB
|
Rythmodan (Capsule) | Disopyramide | Cardiovascular System | No data available |
|
Rythmodan 150mg capsules
0203020F0BCABAC
|
Rythmodan (Capsule) | Disopyramide | Cardiovascular System | No data available |
|
Rythmodan 50mg/5ml solution for injection ampoules
0203020G0BDAAAF
|
Rythmodan (Injection/Tablet) | Disopyramide phosphate | Cardiovascular System | No data available |
|
S-Bicarb 600mg tablets
0902013S0BCAAAP
|
S-Bicarb (Supplements) | Sodium bicarbonate | Nutrition and Blood | No data available |
|
S-Bicarb SF 420mg/5ml (1mmol/ml) oral solution
0101012B0BGAAAB
|
S-Bicarb SF | Sodium bicarbonate | Gastro-Intestinal System | No data available |
|
S-Canister kit
20032200010
|
S-Canister kit | Wound Management & Other Dressings | Dressings | No data available |
|
S-Chlor 292.5mg/5ml (1mmol/ml) oral solution
0902012L0BDAADD
|
S-Chlor | Sodium chloride | Nutrition and Blood | No data available |
|
S.Gard 20mg capsules
0401010ADBCBKBM
|
Melatonin (Proprietary preparations) | Melatonin | Central Nervous System | No data available |
|
Sabervel 150mg tablets
0205052I0BDABAB
|
Sabervel | Irbesartan | Cardiovascular System | No data available |
|
Sabervel 300mg tablets
0205052I0BDACAC
|
Sabervel | Irbesartan | Cardiovascular System | No data available |
|
Sabervel 75mg tablets
0205052I0BDAAAA
|
Sabervel | Irbesartan | Cardiovascular System | No data available |
|
Saccharin sodium powder
190800000AABBBB
|
Generic compound preparation BNF 1908000 | Other colour, flavour and sweetening preparations | Other Drugs and Preparations | No data available |
|
Saccharomyces Boulardii capsules
091104000AAAUAU
|
Generic compound preparation BNF 0911040 | Other digestive aid preparations | Nutrition and Blood | No data available |
|
Sacrosidase 8,500units/ml oral solution
0908010Y0AAAAAA
|
Sacrosidase | Sacrosidase | Nutrition and Blood | No data available |
|
Safe-T-Pro Uno lancets 0.63mm/23gauge
21010900740
|
Safe-T-Pro Uno lancets 0.63mm/23gauge | Other Appliances | Appliances | No data available |
|
Safehold body strap with tube holders
22801978003
|
Safehold body strap with tube holders | Tubing And Accessories | Incontinence Appliances | No data available |
|
Safehold G strap
22801978000
|
Safehold G strap | Tubing And Accessories | Incontinence Appliances | No data available |
|
Safehold G strap, knee strap and ankle strap
22801978002
|
Safehold G strap, knee strap and ankle strap | Tubing And Accessories | Incontinence Appliances | No data available |
|
Safehold knee strap and ankle strap
22801978001
|
Safehold knee strap and ankle strap | Tubing And Accessories | Incontinence Appliances | No data available |
|
SafetyGel 800ml absorbent powder sachets
190500000BBDUA0
|
Proprietary compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
SafetyGel absorbent powder
190500000BBDTA0
|
Proprietary compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
SafetyGel absorbent tablets large
190500000BBDVA0
|
Proprietary compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
SafetyGel absorbent tablets small
190500000BBDWA0
|
Proprietary compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.